glp-1 agonist. The Buzz Around Agonists & Their Role in Weight Loss Comparing Ozempic, Wegovy and Other

These medications lower blood sugar by enhancing insulin release, reducing glucagon secretion, and slowing the emptying of the stomach

Over-reliance on pharmacotherapy without adequate commitment to lifestyle interventions may obfuscate underlying etiologies

The next generation of treatments GLP-1 receptor agonists have transformed the management of type 2 diabetes and obesity, but their therapeutic potential extends far beyond glucose regulation

[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Del Prato S., Kahn S

Clinical data analysis suggests that metformin use reduces the risk of malignancies by approximately 30% [10] and significantly decreases tumor-related mortality in patients with type 2 diabetes [103]

12, Oct